Casdin Capital, LLC Pacific Biosciences Of California, Inc. Transaction History
Casdin Capital, LLC
- $1.29 Billion
- Q3 2024
A detailed history of Casdin Capital, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 1,035,859 shares of PACB stock, worth $1.92 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,035,859
Previous 1,035,859
-0.0%
Holding current value
$1.92 Million
Previous $1.42 Million
24.03%
% of portfolio
0.14%
Previous 0.12%
Shares
5 transactions
Others Institutions Holding PACB
# of Institutions
254Shares Held
228MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$61.8 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$43.7 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$43.3 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$37.6 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$32.6 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $416M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...